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Neurologic 
Manifestations of 
Pandemic (H1N1) 
2009 Virus 
Infection 
To the Editor: In April 2009, 
the outbreak of inﬂ  uenza A pandemic 
(H1N1) 2009 virus was reported. Sub-
sequently, the disease spread through-
out the world, and the pandemic alert 
level was raised to level 6 in June by 
the World Health Organization. Pan-
demic (H1N1) 2009 virus infection 
spread to Thailand and is now found 
throughout Thailand. Similar to the 
effects of other viruses, pandemic 
(H1N1) 2009 virus may cause neuro-
logic complications. Associated neu-
rologic symptoms were ﬁ  rst reported 
from Dallas, Texas, USA: 4 children 
experienced unexplained seizures or 
had an alteration of consciousness 
level that was associated with this vi-
rus (1). We report an adult patient with 
pandemic (H1N1) 2009 infection who 
had neurologic complications.
A 34-year-old man, previously 
healthy, was admitted to Chaiyaphum 
Hospital in Chaiyaphum, Thailand, on 
August 24, 2009, with inﬂ  uenza-like 
symptoms. Two days after admission, 
progressive quadriparesis with bilater-
al, symmetric paresthesia (glove-and-
stocking pattern), and areﬂ  exia  de-
veloped. His motor weakness (grades 
III/V) began in both legs and then 
involved both arms and hands. Other 
neurologic examinations showed limi-
tation of extraocular movement in all 
directions, normal pupil size and light 
reﬂ  ex, and facial diplegia. A lumbar 
puncture was performed, and cerebro-
spinal  ﬂ   uid (CSF) contained neither 
leukocytes nor erythrocytes, with a 
protein level of 19.5 mg/dL.
On day 3 after the patient’s ad-
mission, acute respiratory failure de-
veloped. A nasopharyngeal aspirate 
specimen was positive for pandemic 
(H1N1) 2009 virus by PCR. The pa-
tient received oseltamivir, zanamivir, 
and ventilator support. His chest ra-
diograph showed diffuse alveolar in-
ﬁ  ltration. On day 10, his motor weak-
ness worsened to grade 0, and his 
consciousness level was diminished to 
a drowsy state.
A computed tomography scan of 
the brain showed diffuse white mat-
ter lesions (Figure). Repeated lumbar 
punctures continued to show CSF 
ﬁ   ndings within the reference range. 
An electrophysiologic study, electro-
myogram, and nerve conduction study 
showed polyneuropathy, axonopathy 
type. Guillain-Barré syndrome was 
suspected, and intravenous immuno-
globulin was given for 5 days. Tests 
for GQ1b and GM1 antibodies were 
carried out at Oxford University; re-
sults were negative.
Other laboratory tests showed 
mild transaminitis and negative results 
for syphilis testing and for serologic 
tests for HIV, hepatitis B virus, hepa-
titis C virus, Japanese encephalitis 
virus, herpes simplex virus, and My-
coplasma pneumoniae. A CSF antigen 
test was negative, and CSF culture 
was negative for bacteria. Meropenem 
was given to treat ventilator-associat-
ed pneumonia, which was caused by 
β-lactam–resistant  Klebsiella pneu-
moniae. After a month of treatment, 
the patient regained consciousness, 
his motor strength improved consider-
ably, and he was able to be gradually 
removed from the ventilator. After 3 
months, he was discharged with self-
assisted status. 
Our report shows neurologic 
manifestations associated with pan-
demic (H1N1) 2009 virus infection in 
an adult. The manifestation of progres-
sive quadriplegia with diffuse sensory 
loss is compatible with a polyneuropa-
thy. The neurologic signs developed 2 
days after the respiratory tract signs.
Although a diagnosis of Guil-
lain-Barré syndrome was considered 
initially, according to the National 
Institute of Neurologic Disorders and 
Stroke criteria (2), some clinical fea-
tures did not support this diagnosis. 
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These included the lack of CSF albu-
minocytologic dissociation, the fact 
that the clinical signs occurred dur-
ing the outbreak of pandemic (H1N1) 
2009 virus infection rather than after 
it, and the fact that antibodies were 
not found in gangliosides. CSF albu-
minocytologic dissociation and serum 
ganglioside antibodies may be found 
in 85%–90% of Guillain-Barré syn-
drome patients (2).
Alternatively, the patient might 
have had central nervous system com-
plication from pandemic (H1N1) 2009 
virus infection. Acute disseminated 
encephalomyelitis is a condition that 
might occur within 30 days after an 
infectious process (3). It can lead to 
quadriplegia and diffuse white matter 
lesions. The clinical feature that makes 
acute disseminated encephalomyeli-
tis less likely in this patient was the 
CSF ﬁ  ndings in the reference range. 
In summary, however, we believe that 
pandemic (H1N1) 2009 virus infection 
can cause neurologic complications af-
fecting both the peripheral and central 
nervous systems in adult patients.
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Rickettsia felis, 
West Indies
To the Editor: A spay–neuter 
(sterilization) program for feral cats 
from Basseterre, the capital of the 
Caribbean Island St. Kitts, found that 
most (45/58; 66%) cats had antibod-
ies to spotted fever group rickettsiae 
(SFGR). The antibodies were detected 
with Rickettsia rickettsii antigen in a 
standard microimmunoﬂ  uorescence 
assay (1). Titers for 13 (20%) cats 
were >320. 
Most SFGR are transmitted by 
ticks, but because of their grooming 
habits, cats seldom have many ticks 
(2), and we did not ﬁ  nd any ticks on the 
cats we saw through the program. We 
did, however, commonly ﬁ  nd cat ﬂ  eas, 
Ctenocephalides felis, which are the 
main vector of R. felis, a recently de-
scribed member of the SFGR. R. felis 
seems to be apathogenic in cats (3) but 
is the agent of ﬂ  ea-borne spotted fever 
in humans (4). Although R. felis has 
been reported from North and South 
America, Europe, Africa, the Middle-
East, and Oceania (4), its presence in 
the Caribbean islands has not been 
established. To provide this informa-
tion we tested DNA extracted with the 
QIAamp DNA Mini-Kit (QIAGEN, 
Valencia, CA, USA) from C. felis ﬂ  eas 
preserved in 70% ethanol.
Of 57 (19%) C. felis ﬂ  eas from 
St. Kitts, 11 were positive for R. felis 
DNA when tested by PCR using prim-
ers targeting SFGR ompA (5) or Taq-
Man assay using primers targeting gltA 
and a probe speciﬁ  c for the organism 
(6,7). For a negative control we used 
distilled water; for a positive control 
we used DNA from R. montanensis 
cultures or recombinant control plas-
mids constructed by amplifying target 
fragments from R. typhi strain Wilm-
ington and R. felis strain LSU (7). The 
sequences of the ompA and gltA am-
plicons obtained had 100% nucleotide 
sequence similarity with homologous 
fragments of the type reference isolate 
R. felis URRxCal2. We used the Na-
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Figure. Computed tomography images of the brain of an adult patient with pandemic 
(H1N1) 2009 virus infection and neurologic signs. A noncontrast study showed hypodense 
lesions in both occipital lobes (A) and in both upper parietal lobes (B).